S. K. Naineni

A second-generation eIF4A RNA helicase inhibitor exploits translational reprogramming as a vulnerability in triple-negative breast cancer

R. Cencic, A. Koromilas, T. Schmeing, 2024, Proceedings of the National Academy of Sciences of the United States of America.

C8ORF88: A Novel eIF4E-Binding Protein

R. Cencic, S. Naineni, Mehdi Amiri, 2023, Genes.

A comparative study of small molecules targeting eIF4A

R. Cencic, J. Pelletier, Abimael D Rodríguez, 2020, RNA.

A CRISPR-based Screen Links an Inhibitor of Nonsense-mediated Decay to eIF4A3 Target Engagement.

R. Cencic, J. Pelletier, S. Naineni, 2020, ACS chemical biology.

Targeting DEAD‐box RNA helicases: The emergence of molecular staples

J. Pelletier, B. Nagar, F. Robert, 2022, Wiley interdisciplinary reviews. RNA.